Research Activity

Homogeneous transition metal catalysis: i) asymmetric catalysis; ii) design and synthesis of supramolecular catalysts; iii) development of sustainable and efficient reduction methodologies (iron catalyzed reductions, asymmetric hydrogenation of pyridines and tandem metathesis-hydrogenation processes).

Synthesis of targeted cytotoxic agents: development of new peptide / peptidomimetic ligands of tumor-associated receptors (e.g. integrins and vascular endothelial growth factor receptors) and their conjugation to cytotoxic, pro-apoptotic or fluorescent compounds for tumor diagnosis and therapy. 

News

Latest Publications

"Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker" - L. Bisbal Lopez, A. Dal Corso et al. Front. Pharmacol. 2023, DOI: 10.3389/fphar.2023.1320524

"A Tight Contact: the Expanding Application of Salicylaldehydes in Lysine-targeting Covalent Drugs" - M. Mason, A. Dal Corso et al. ChemBioChem 2023, DOI: 10.1002/cbic.202300743

"Visible Light-Promoted β-Functionalization of Carbonyl Compounds in the Presence of Organic Dyes" - L. Dolcini, L. Pignataro et al. J. Org. Chem. 2023,  88, 14283–14291